MAPT and Alzheimer disease: The ATN framework is a research-only framework and signs the line between AD and dementia; indeed, AD clinical presentation within the AD continuum also includes slight cognitive detriment, which is not dementia per se, and, further, non-AD dementia patients never display the presence of both Aβ and phosphorylated Tau [2,14].